13F Insight

Frankenius Equity AB

CIK: 0001988262
10% Owner
Primary company: TriSalus Life Sciences, Inc. (TLSI)

Frankenius Equity AB is a corporate insider at TriSalus Life Sciences, Inc. (TLSI) filing SEC Form 4 transactions. 2 transactions, totaling $249,999 in purchases and $0 in sales. Source: SEC EDGAR.

Total Transactions
2
Total Buy Value
$250K
Total Sell Value
$0
Net Activity
+$250K
Last Transaction
Feb 2025
Companies
1

Companies

Transaction History

Source: SEC EDGAR Form 4 insider transaction filings.

Type
Conversion
Shares
759,000
Price
$4.00
Value
$3.04M
Type
Conversion
Shares
759,000
Price
-
Value
-
Type
J
Shares
205,853
Price
$5.28
Value
$1.09M
Type
Purchase
Shares
62,972
Price
$3.97
Value
$250K